ExploreOutcomeType 2 diabetes mellitus
Outcome

Type 2 diabetes mellitus

Also known as: 2-year incidence of type 2 diabetes mellitus Adult-Onset Diabetes Mellitus Diabetes Mellitus, Adult Onset Diabetes Mellitus, Adult-Onset Diabetes Mellitus, Ketosis Resistant Diabetes Mellitus, Ketosis-Resistant Diabetes Mellitus, Maturity Onset Diabetes Mellitus, Maturity-Onset Diabetes Mellitus, Non Insulin Dependent Diabetes Mellitus, Non-Insulin-Dependent Diabetes Mellitus, Noninsulin Dependent Diabetes Mellitus, Noninsulin-Dependent +42 more
6 findings 1 paper 4 related entities View in graph →

Related entities

interventions
populations
studys

Findings (50)

None
improvement

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Size: HR 0.46 CI: 95% CI 0.29-0.71
None
improvement

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Size: HR 0.46 CI: 95% CI 0.29-0.71
None
improvement

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Size: HR 0.46 CI: 95% CI 0.29-0.71
None
improvement

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Size: HR 0.46 CI: 95% CI 0.29-0.71
None
improvement

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Size: HR 0.46 CI: 95% CI 0.29-0.71
None
improvement

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Size: HR 0.46 CI: 95% CI 0.29-0.71
None
improvement

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Size: HR 0.46 CI: 95% CI 0.29-0.71
None
improvement

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Size: HR 0.46 CI: 95% CI 0.29-0.71
None
improvement

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Size: HR 0.46 CI: 95% CI 0.29-0.71
None
improvement

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Size: HR 0.46 CI: 95% CI 0.29-0.71
None
improvement

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Size: HR 0.46 CI: 95% CI 0.29-0.71
None
improvement

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Size: HR 0.46 CI: 95% CI 0.29-0.71
None
improvement

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Size: HR 0.46 CI: 95% CI 0.29-0.71
None
improvement

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Size: HR 0.46 CI: 95% CI 0.29-0.71
None
improvement

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Size: HR 0.46 CI: 95% CI 0.29-0.71
None
improvement

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Size: HR 0.46 CI: 95% CI 0.29-0.71
None
improvement

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Size: HR 0.46 CI: 95% CI 0.29-0.71
None
improvement

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Size: HR 0.46 CI: 95% CI 0.29-0.71
None
improvement

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Size: HR 0.46 CI: 95% CI 0.29-0.71
None
improvement

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Size: HR 0.46 CI: 95% CI 0.29-0.71
None
improvement

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Size: HR 0.46 CI: 95% CI 0.29-0.71
None
improvement

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Size: HR 0.46 CI: 95% CI 0.29-0.71
None
improvement

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Size: HR 0.46 CI: 95% CI 0.29-0.71
None
improvement

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Size: HR 0.46 CI: 95% CI 0.29-0.71
None
improvement

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Size: HR 0.46 CI: 95% CI 0.29-0.71
None
improvement

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Size: HR 0.46 CI: 95% CI 0.29-0.71
None
improvement

Higher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi

Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71

Size: HR 0.46 CI: 95% CI 0.29-0.71
None
improvement

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Size: HR 0.43 CI: 95% CI 0.22-0.82
None
improvement

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Size: HR 0.43 CI: 95% CI 0.22-0.82
None
improvement

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Size: HR 0.43 CI: 95% CI 0.22-0.82
None
improvement

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Size: HR 0.43 CI: 95% CI 0.22-0.82
None
improvement

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Size: HR 0.43 CI: 95% CI 0.22-0.82
None
improvement

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Size: HR 0.43 CI: 95% CI 0.22-0.82
None
improvement

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Size: HR 0.43 CI: 95% CI 0.22-0.82
None
improvement

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Size: HR 0.43 CI: 95% CI 0.22-0.82
None
improvement

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Size: HR 0.43 CI: 95% CI 0.22-0.82
None
improvement

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Size: HR 0.43 CI: 95% CI 0.22-0.82
None
improvement

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Size: HR 0.43 CI: 95% CI 0.22-0.82
None
improvement

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Size: HR 0.43 CI: 95% CI 0.22-0.82
None
improvement

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Size: HR 0.43 CI: 95% CI 0.22-0.82
None
improvement

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Size: HR 0.43 CI: 95% CI 0.22-0.82
None
improvement

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Size: HR 0.43 CI: 95% CI 0.22-0.82
None
improvement

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Size: HR 0.43 CI: 95% CI 0.22-0.82
None
improvement

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Size: HR 0.43 CI: 95% CI 0.22-0.82
None
improvement

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Size: HR 0.43 CI: 95% CI 0.22-0.82
None
improvement

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Size: HR 0.43 CI: 95% CI 0.22-0.82
None
improvement

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Size: HR 0.43 CI: 95% CI 0.22-0.82
None
improvement

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Size: HR 0.43 CI: 95% CI 0.22-0.82
None
improvement

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Size: HR 0.43 CI: 95% CI 0.22-0.82
None
improvement

Longer duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas

Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82

Size: HR 0.43 CI: 95% CI 0.22-0.82

Papers (1)